Figure 6.

Prognostic Implication of the Gene Signature in the Training and Validation Sets. Patients were divided into high‐risk and low‐risk groups. Anaplastic gliomas (AG) patients with high‐risk scores had worse prognoses than low‐risk patients in both TCGA and CGGA datasets. Moreover, postcontrast enhanced AG patients were stratifiable by this risk signature. CE, contrast enhancement; CGGA, Chinese Glioma Genome Atlas; HR, hazard ratio (95% confidence interval); TCGA, The Cancer Genome Atlas